IGF2BP3 and myocardial infarction: Triphenyltetrazolium chloride (TTC) staining indicated that IGF2BP3 significantly reduced myocardial infarction size, as determined by the increased red-stained area (Fig. 4D), while Masson trichrome staining showed that it significantly reduced myocardial fibrosis (Fig. 4E).